Black Diamond Therapeutics (BDTX) Competitors $3.25 -0.12 (-3.56%) Closing price 04:00 PM EasternExtended Trading$3.27 +0.02 (+0.62%) As of 05:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BDTX vs. RZLT, RLAY, IMTX, MRVI, KROS, TERN, TRML, SIGA, PVLA, and IVAShould you be buying Black Diamond Therapeutics stock or one of its competitors? The main competitors of Black Diamond Therapeutics include Rezolute (RZLT), Relay Therapeutics (RLAY), Immatics (IMTX), Maravai LifeSciences (MRVI), Keros Therapeutics (KROS), Terns Pharmaceuticals (TERN), Tourmaline Bio (TRML), Siga Technologies (SIGA), Palvella Therapeutics (PVLA), and Inventiva (IVA). These companies are all part of the "pharmaceutical products" industry. Black Diamond Therapeutics vs. Its Competitors Rezolute Relay Therapeutics Immatics Maravai LifeSciences Keros Therapeutics Terns Pharmaceuticals Tourmaline Bio Siga Technologies Palvella Therapeutics Inventiva Rezolute (NASDAQ:RZLT) and Black Diamond Therapeutics (NASDAQ:BDTX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, media sentiment, valuation and institutional ownership. Which has higher earnings and valuation, RZLT or BDTX? Rezolute is trading at a lower price-to-earnings ratio than Black Diamond Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRezoluteN/AN/A-$68.46M-$1.15-6.69Black Diamond TherapeuticsN/AN/A-$69.68M$0.2314.13 Does the media favor RZLT or BDTX? In the previous week, Rezolute had 3 more articles in the media than Black Diamond Therapeutics. MarketBeat recorded 6 mentions for Rezolute and 3 mentions for Black Diamond Therapeutics. Black Diamond Therapeutics' average media sentiment score of 1.31 beat Rezolute's score of 0.99 indicating that Black Diamond Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Rezolute 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Black Diamond Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders hold more shares of RZLT or BDTX? 83.0% of Rezolute shares are owned by institutional investors. Comparatively, 95.5% of Black Diamond Therapeutics shares are owned by institutional investors. 18.4% of Rezolute shares are owned by company insiders. Comparatively, 6.0% of Black Diamond Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Do analysts recommend RZLT or BDTX? Rezolute presently has a consensus target price of $11.67, suggesting a potential upside of 51.71%. Black Diamond Therapeutics has a consensus target price of $11.67, suggesting a potential upside of 258.97%. Given Black Diamond Therapeutics' higher probable upside, analysts plainly believe Black Diamond Therapeutics is more favorable than Rezolute.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Rezolute 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20Black Diamond Therapeutics 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.14 Which has more risk & volatility, RZLT or BDTX? Rezolute has a beta of 0.03, meaning that its stock price is 97% less volatile than the S&P 500. Comparatively, Black Diamond Therapeutics has a beta of 2.93, meaning that its stock price is 193% more volatile than the S&P 500. Is RZLT or BDTX more profitable? Black Diamond Therapeutics' return on equity of 12.70% beat Rezolute's return on equity.Company Net Margins Return on Equity Return on Assets RezoluteN/A -70.09% -63.08% Black Diamond Therapeutics N/A 12.70%9.58% SummaryBlack Diamond Therapeutics beats Rezolute on 9 of the 13 factors compared between the two stocks. Get Black Diamond Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BDTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BDTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BDTX vs. The Competition Export to ExcelMetricBlack Diamond TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$185.06M$3.12B$5.79B$10.15BDividend YieldN/A2.32%5.69%4.61%P/E Ratio14.1321.3074.5925.92Price / SalesN/A258.83454.0285.55Price / CashN/A45.3337.0859.91Price / Book2.219.6112.156.29Net Income-$69.68M-$53.29M$3.28B$270.85M7 Day Performance10.54%0.28%0.98%3.35%1 Month Performance27.95%8.90%7.20%6.40%1 Year Performance-44.44%13.14%63.06%28.21% Black Diamond Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BDTXBlack Diamond Therapeutics3.5612 of 5 stars$3.25-3.6%$11.67+259.0%-45.0%$185.06MN/A14.1390Positive NewsRZLTRezolute2.6168 of 5 stars$7.12-1.4%$12.50+75.6%+55.1%$619.41MN/A0.0040News CoveragePositive NewsUpcoming EarningsRLAYRelay Therapeutics2.9196 of 5 stars$3.59-2.7%$17.08+375.9%-46.9%$618.96M$10.01M0.00330Positive NewsIMTXImmatics2.9304 of 5 stars$5.09-3.6%$14.67+188.1%-49.4%$618.69M$168.65M0.00260Positive NewsHigh Trading VolumeMRVIMaravai LifeSciences3.5646 of 5 stars$2.42+1.7%$5.22+115.7%-68.3%$617.98M$259.18M-1.78610Positive NewsGap UpKROSKeros Therapeutics3.4786 of 5 stars$15.21-0.3%$30.00+97.2%-71.2%$617.76M$3.55M49.06100Positive NewsTERNTerns Pharmaceuticals4.0117 of 5 stars$6.96-1.6%$15.63+124.5%-30.3%$609.08MN/A-6.6940Positive NewsTRMLTourmaline Bio0.9085 of 5 stars$23.40+1.6%$50.14+114.3%+165.6%$601.20MN/A-6.8244Trending NewsAnalyst DowngradeSIGASiga Technologies1.6276 of 5 stars$8.39+2.2%N/A+20.8%$600.77M$138.72M7.4240Positive NewsPVLAPalvella Therapeutics1.8935 of 5 stars$54.15+5.6%$58.50+8.0%N/A$598.88M$42.81M0.00N/AAnalyst ForecastIVAInventiva3.1584 of 5 stars$6.19-2.5%$13.00+110.0%+157.6%$592.15M$9.95M0.00100Positive NewsShort Interest ↑Gap DownHigh Trading Volume Related Companies and Tools Related Companies RZLT Competitors RLAY Competitors IMTX Competitors MRVI Competitors KROS Competitors TERN Competitors TRML Competitors SIGA Competitors PVLA Competitors IVA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BDTX) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored6-Figure Target for BTC by 2025Trump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredWall Street laughed at Trump’s “Smart Dollar.” Now they’re all in."THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Black Diamond Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Black Diamond Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BDTX Stock Alerts